Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Artificial Cartilage Could Help People Regain Mobility

By HospiMedica International staff writers
Posted on 27 Jun 2017
Self-assembled artificial cartilage grown under tension, but without a supporting scaffold, shows similar mechanical and biochemical properties to those of natural cartilage, according to a new study.

Developed by researchers at the University of California Davis (UCD; Sacramento, USA) and Stanford University (CA, USA), the tissue is grown from human chondrocytes in a scaffold-free system, which represents natural conditions more closely. More...
During the self-assembly process, the articular cartilage is placed under tension, which together with matrix remodeling and synthesis agents leads to neocartilage with tensile properties approaching those of native tissue.

The researchers successfully showed that the tension stimulation could generate enhanced anisotropic human neocartilage with a nearly six-fold improvement in tensile properties over unstimulated tissue, which could allow the engineering of mechanically robust biological replacements for native tissue. The researchers also demonstrated that implantation of the tension-stimulated cartilage tissues resulted in the formation of a tissue morphologically reminiscent of native cartilage. The study was published on June 12, 2017, in Nature Materials.

“We can finally engineer tissue that has the tensile and compressive characteristics of native tissue; the artificial cartilage that we engineer is fully biological with a structure akin to real cartilage,” said senior author Professor Kyriacos Athanasiou, PhD, of the UCD department of biomedical engineering. “Most importantly, we believe that we have solved the complex problem of making tissues in the laboratory that are strong and stiff enough to take the extremely high loads encountered in joints such as the knee and hip.”

Cartilage structures and functions can be damaged due to a variety of causes, such as a fall or traumatic sport-accident, previous knee injuries, or wear and tear over time. Unfortunately, articular cartilage does not usually regenerate after injury or disease, leading to loss of tissue and formation of a defect.

Related Links:
University of California Davis
Stanford University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.